The Effect of Dihydrotestosterone (DHT) on Prostate Tissue Androgen Concentrations and Inflammation in Normal Men.

Trial Profile

The Effect of Dihydrotestosterone (DHT) on Prostate Tissue Androgen Concentrations and Inflammation in Normal Men.

Completed
Phase of Trial: Phase I/II

Latest Information Update: 08 Jun 2011

At a glance

  • Drugs Androstanolone (Primary)
  • Indications Hypogonadism
  • Focus Pharmacodynamics
  • Acronyms DHT-3
  • Most Recent Events

    • 22 Jun 2010 Results (n=31) presented at the 92nd Annual Meeting of the Endocrine Society
    • 14 Apr 2009 Actual number of patients (43) added as reported by ClinicalTrials.gov.
    • 14 Apr 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top